The 4x premium to the current OTC price ($4.00 vs $1.00) creates substantial risk that institutional investors may balk at the valuation. Monitor the final prospectus for NASDAQ listing approval - if the application is denied, the offering terminates per the filing's own terms. The going-concern doubt means this IPO is existential; failure to close would likely trigger a substantial price decline and potential equity raise at distressed levels.
Executive Summary
Veri MedTech Holdings (VRHI), a healthcare technology platform primarily connecting patients with medical cannabis physicians, filed Amendment No. 4 to its S-1 IPO registration statement. The company is offering 3,750,000 shares at $4.00/share for gross proceeds of $15 million ($13.35M net) via firm commitment underwriting. Revenue declined ~35% YoY in FY2025 to ~$10.8M with a net loss of ~$2.32M, and the auditor raised substantial doubt about the company's ability to continue as a going concern without the IPO proceeds. The offering price of $4.00 represents a 400% premium to the most recent OTC closing price of $1.00/share as of June 2, 2026.
Key Financial Metrics
Key Facts
- Offering 3,750,000 shares of common stock at $4.00/share via firm commitment underwriting
- Net proceeds to company estimated at $13.35 million (excluding over-allotment)
- Revenue declined ~35% YoY in FY2025 to approximately $10.8 million from $16.7 million in FY2024
- Net loss of approximately $2.32 million in FY2025 vs. $409,000 loss in FY2024
- Auditor's going concern opinion: working capital deficit of ~$2.15M and accumulated deficit of ~$5.04M as of March 31, 2026
- Company has applied to list on NASDAQ Capital Market; offering contingent on listing approval
- Existing stockholders will hold >50% voting power post-offering via Series A Preferred Stock with 80% voting control
- New investors face immediate dilution of $3.54 per share (88.5% of offering price)
- As of June 2, 2026, last reported OTC price was $1.00/share - a 75% discount to the $4.00 offering price
Financial Impact
Gross proceeds of $15M at $4.00/share, net proceeds ~$13.35M. The $4.00 offering price is priced at 4x the latest OTC market price of $1.00, creating significant execution risk if the existing trading venue discount persists.
Risk Factors
- Going concern risk - company requires IPO proceeds to fund operations beyond 3-6 months
- Offering price of $4.00 is 4x the $1.00 OTC closing price - significant execution and valuation risk
- Offering is contingent on NASDAQ Capital Market listing approval, which is not guaranteed
- Revenue declining 35% YoY with no sign of stabilization - regulatory headwinds in key states (FL, AZ, CO)
- Executive officers control 80% voting power via Series A Preferred, creating governance concentration risk
- Immediate 88.5% dilution for new investors vs. net tangible book value post-offering
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001096906-26-000909 |
| Document: vrhi_ex5z1.htm | 0001096906-26-000909 |
| Document: vrhi_ex23z1.htm | 0001096906-26-000909 |
| Document: 0001096906-26-000909-index-headers.html | 0001096906-26-000909 |
| Document: 0001096906-26-000909-index.html | 0001096906-26-000909 |
| Document: 0001096906-26-000909.txt | 0001096906-26-000909 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 9, 2026 19w ago | S-1/A | $2.45 $4.89 | ▲ +99.33% | ▲ +97.08% | $4.41 (+79.89%) |
Jun 2, 2026 20w ago | S-1/A | $1.00 $1.95 | ▲ +95.46% | ▲ +96.46% | $4.41 (+341.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers